← Back to Search

Behavioural Intervention

High-Intensity Interval Training (HIIT) Breaks for Aging (HIIT2SITLess Trial)

N/A
Waitlist Available
Led By Dominika M Pindus, Ph.D.
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Good or corrected vision and hearing
Age 60-75 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately before intervention, 2 x during the intervention (50 min and 120 min into the intervention), and immediately after the intervention
Awards & highlights

HIIT2SITLess Trial Summary

This trial will study if taking short breaks every 30 minutes to do high intensity interval training (HIIT) exercises can improve brain health in older adults. The study will compare the effects of HIIT

Who is the study for?
This trial is for cognitively normal older adults interested in improving brain health. Participants should be able to sit for long periods and perform both high-intensity and light-intensity exercises. Specific inclusion or exclusion criteria are not provided, but typically these would relate to age, mobility, cognitive baseline status, and the absence of certain medical conditions.Check my eligibility
What is being tested?
The study is testing if taking breaks from sitting with either high-intensity interval training (HIIT) or light-intensity interval training (LIIT) affects brain function in older adults. It will compare the effects of short HIIT versus LIIT breaks on mental performance after sitting for extended times.See study design
What are the potential side effects?
Potential side effects may include typical exercise-related risks such as muscle soreness, fatigue, or strain injuries. High intensity workouts could also pose cardiovascular stress especially in individuals with underlying heart conditions.

HIIT2SITLess Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My vision and hearing are good or corrected.
Select...
I am between 60 and 75 years old.
Select...
I sit for 6 or more hours a day.
Select...
I am cleared by a doctor for intense exercise.
Select...
I showed no signs of heart disease during my exercise test.

HIIT2SITLess Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately before intervention and immediately after the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately before intervention and immediately after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in task-evoked brain activity
Secondary outcome measures
Change in cognitive functions
Change in resting stated and task evoked brain activity

HIIT2SITLess Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: High-Intensity Interval Training (HIIT) BreaksActive Control1 Intervention
Sitting interrupted every 30 min by 6-min HIIT bouts.
Group II: Light-Intensity Interval Training (HIIT) BreaksPlacebo Group1 Intervention
Sitting interrupted every 30 min by 6-min LIIT bouts.

Find a Location

Who is running the clinical trial?

University of Illinois at Urbana-ChampaignLead Sponsor
189 Previous Clinical Trials
37,331 Total Patients Enrolled
14 Trials studying Aging
1,801 Patients Enrolled for Aging
Northeastern UniversityOTHER
89 Previous Clinical Trials
61,272 Total Patients Enrolled
4 Trials studying Aging
423 Patients Enrolled for Aging
National Institute on Aging (NIA)NIH
1,676 Previous Clinical Trials
28,021,445 Total Patients Enrolled
160 Trials studying Aging
75,953 Patients Enrolled for Aging

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for patient participation in this clinical trial?

"The current data on clinicaltrials.gov indicates that this specific trial is not actively seeking participants. Despite being initially listed for recruitment on 1/31/2024 and last revised on 1/29/2024, there are currently 226 other trials actively looking for eligible candidates."

Answered by AI

Is the research study open to individuals above the age of 30?

"Participants between the ages of 60 and 75 are eligible for inclusion in this research. Notably, there is one study available for individuals under 18 years old and a substantial number of trials - specifically, 218 studies - targeting participants over the age of 65."

Answered by AI
~36 spots leftby May 2026